Professional Documents
Culture Documents
Qualisa Vitamin-D
Qualisa Vitamin-D
Qualisa Vitamin-D
TM
INTRODUCTION
Vitamin D is a steroid hormone responsible for enhancing intestinal absorption of calcium and the regulation of its
homeostasis. There are two common forms of Vitamin D: Vitamin D2 and D3. Vitamin D3 is naturally produced in the human skin
through the exposure to ultraviolet light and Vitamin D2 is mainly obtained from plant foods. Vitamin D is transported to the liver
where it is metabolized to 25-hydroxy Vitamin D. In medicine, a total 25-hydroxy Vitamin D test is used to determine Vitamin D
concentration in the body. The blood concentration of 25-hydroxy Vitamin D (including D2 and D3) is considered the best
indicator of Vitamin D status.
SAMPLE COLLECTION
1. Collect Blood specimen by venipuncture according to Calibrators procedure.
2. Serum only should be used.
3. Avoid grossly hemolytic, lipemic or turbid samples.
4. Preferably use fresh samples. However specimens can be stored up to 48 hours at 2-8°C, for short duration.
5. For longer storage, specimens can be frozen at -20°C. Thawed samples must be mixed prior to testing.
6. Do not heat inactivate before use.
7. Specimen containing particulate matter should be clarified by centrifugation prior to use.
PRECAUTIONS
1. Bring all reagents and specimen to room temperature before use.
2. Do not pipette any material by mouth.
3. Do not eat, drink or smoke in the area where testing is done.
4. Use protective clothing and wear gloves when handling samples.
5. Use absorbent sheet to cover the working area.
6. Immediately clean up any spills with sodium hypochlorite.
7. Dispose off all the reagents and material used as if they contain infectious agent.
8. Neutralize acid containing waste before adding hypochlorite.
9. Do not use kit after the expiry date.
10. Do not mix components of one kit with another.
11. Always use new tip for each specimen and reagent.
12. Do not allow liquid from one well to mix with other wells.
13. Do not let the strips dry in between the steps.
REAGENT PREPARATION
1. All reagents should be brought to room temperature (18-25°C) and mixed by gently inverting or swirling prior to use. Do
NOT induce foaming.
2. Dilute wash buffer 20 times (for example add 5ml concentrated buffer to 95 ml distilled or deionized water) Mix well before
use.
TEST PROCEDURE
1. Secure the desired number of coated wells in the holder. Dispense 10 µl of calibrator, serum, and controls into the
appropriate wells.
2. Dispense 200 µl of Sample Diluent into each well. Gently shake the plate to mix the contents. Incubate at room
temperature (18-25°C), for 20 minutes.
3. Remove the incubation mixture by emptying the plate content into a waste container. Rinse and empty the microtiter
plate 5 times with washing buffer (20X). Strike the microtiter plate sharply onto absorbent paper or paper towels to
remove all residual water droplets.
4. Dispense 100 µl of enzyme conjugate reagent into each well. Incubate at room temperature(18-25°C) for 10 mins.
5. Remove the incubation mixture by emptying the plate content into a waste container. Rinse and empty the microtiter
plate 5 times with washing buffer (20X). Strike the microtiter plate sharply onto absorbent paper or paper towels to
remove all residual
water droplets. Add 10 µl Calibrators/controls/samples into the respective Microwell
6. Dispense 100 µl of
TMB substrate into Add 200 µl Sample diluent into each Microwell and gently shake the plate for 30 seconds
each well. Incubate
at room temperature Apply plate sealer and incubate for 20 minutes at 18-25°C
(18-25°C), in the
dark, for 10 minutes.
7. Stop the reaction by Wash Microwells 5 times with 350 µl of diluted wash buffer
adding 100 µl of Stop
Solution to each well. Add 100 µl Enzyme conjugate in each well
Gently mix for 10
seconds until the Apply plate sealer and incubate for 10 minutes. at 18-25°C
blue color completely
changes to yellow. Wash Microwells 5 times with 350 µl of diluted wash buffer
8. Read the optical
density at 450/630
nm with a microtiter Add 100 µl substrate in each well
plate reader within 15
minutes. Incubate for 10 Minutes. at 18-25oc in dark
This Calibrator curve is for the purpose of illustration only, and should not be used to calculate samples. Each user should
obtain his or her own Calibrators curve and data.
PERFORMANCE CHARACTERISTICS
External Evaluation:
QualisaTM 25-OH Vitamin D is evaluated by a NABL accredited lab against their reference method (ELISA). In this evaluation
QualisaTM 25-OH Vitamin D ELISA demonstrated 100% correlation with the reference method (ELISA).
*Data on file: Qualpro Diagnostics (A Division of Tulip Diagnostics Private Limited)
Internal Evaluation
In an internal evaluation, 300 random samples collected from local lab were evaluated against a reference method (ELISA) &
following is our observations:
Total samples = 300 QualisaTM 25-OH Vitamin D Reference Method
Deficient 26 29
Insufficient 239 236
Sufficient 34 34
Toxicity 1 1
On the basis of the above evaluation data QualisaTM 25-OH Vitamin D has demonstrated 99.0% correlation with reference
method.
16 samples whose LC-MS/MS values have been obtained by a reference lab when tested with QualisaTM 25-OH Vitamin D
and following are the results
IMPORTANT NOTE
1. The wash procedure is critical. Insufficient washing will result in poor precision and falsely elevated absorbance readings.
2. It is recommended to use the multiple channel pippets to avoid time effect. A full plate of 96 wells may be used if
automated pipetting is available.
3. Duplication of Calibrators & samples is not mandatory but may provide information on reproducibility & application errors.
BIBLIOGRAPHY
1. Zerwekh J.E. (2008). Blood biomarkers of Vitamin D status. Am. J.Clin. Nutr., 87(suppl):1087S-91S.
2. Holick M.F. (2006). Resurrection of Vitamin D deficiency and rickets.J. Clin. Invest., 116:2062-2072.
3. Heaney R.P. (2000). Vitamin D: how much do we need, and how much is too much. Osteoporos. Int., 11:553-555.
4. Dawson-Hughes B., Heaney R.P., Holick M.F., Lips P., Meunier P.J.(1997). Prevalence of Vitamin D insufficiency in an
adult normal Population. Osteoporos. Int., 7:439-443.
5. Bischoff-Ferrari H.A., Giovannucci E., Willett W.C., Dietrich T., Dawson-Hughes B. (2006). Estimation of optimal serum
Concentrations of 25-hydroxyVitamin D for multiple health outcomes. Am. J. Clin. Nutr., 84:18-28.
6. Holick M.F (2004). Sunlight and Vitamin D for bone health and Prevention of autoimmune diseases, cancers and
cardiovascular disease. Am. J. Clin. Nutr., 80:16788S-1688S.
7. Heaney R.P. (2010). Defining deficiency of Vitamin D. Clinical Laboratory International, October 2010, vol.34 : 16-19.
8. Holick M.F. (2007). Vitamin D deficiency. N. Engl. J. Med., 357:266-281.
9. Taha N. M.,Vieth R. (2010). The problem of an optimal target level for 25-HydroxyVitamin D, the test for Vitamin D
nutritional status. Clinical Laboratory International, November 2010, vol.34 : 28-30.
Manufactured by:
Qualpro Diagnostics
0919/VER-01